Ripretinib
Ripretinib | |
---|---|
Term | Ripretinib |
Short definition | Ripretinib - (pronounced) (rih-PREH-tih spring) drug used to treat adults with advanced gastrointestinal stromal tumor. It is used in patients whose cancer has already been treated with at least three other kinase inhibitors, including imatinib mesylate. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Ripretinib - (pronounced) (rih-PREH-tih spring) drug used to treat adults with advanced gastrointestinal stromal tumor. It is used in patients whose cancer has already been treated with at least three other kinase inhibitors, including imatinib mesylate. It is also being studied in the treatment of other types of cancer. Ripretinib blocks certain proteins that can prevent cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also called Qinlock
External links
- Medical encyclopedia article on Ripretinib
- Wikipedia's article - Ripretinib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski